Amgen Announces Webcast of 2016 Fourth Quarter and Full Year Financial Results Read more about Amgen Announces Webcast of 2016 Fourth Quarter and Full Year Financial Results
Amgen Receives Positive CHMP Opinion For ABP 501 (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases Read more about Amgen Receives Positive CHMP Opinion For ABP 501 (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases
Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv™ (Etelcalcetide) Significantly Reduced Serum Parathyroid Hormone in Adults With Secondary Hyperparathyroidism on Hemodialysis Read more about Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv™ (Etelcalcetide) Significantly Reduced Serum Parathyroid Hormone in Adults With Secondary Hyperparathyroidism on Hemodialysis
Amgen Statement on January 9, 2017, U.S. District Court Decision Read more about Amgen Statement on January 9, 2017, U.S. District Court Decision
Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies Read more about Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies
Amgen And DaVita Enter Into New Sourcing And Supply Agreement Read more about Amgen And DaVita Enter Into New Sourcing And Supply Agreement
Court Grants Permanent Injunction For Infringement Of Amgen's Repatha® Patents Read more about Court Grants Permanent Injunction For Infringement Of Amgen's Repatha® Patents
Amgen To Present At The 35th Annual J.P. Morgan Healthcare Conference Read more about Amgen To Present At The 35th Annual J.P. Morgan Healthcare Conference
Amgen Announces 15 Percent Increase In 2017 First Quarter Dividend Read more about Amgen Announces 15 Percent Increase In 2017 First Quarter Dividend
Amgen And UCB Announce Submission Of Application For Investigational Osteoporosis Medication Romosozumab In Japan Read more about Amgen And UCB Announce Submission Of Application For Investigational Osteoporosis Medication Romosozumab In Japan
